FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/02/2024
Voltar para busca
Dado oficial do USPTO
COVAFLU
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
06/02/2024
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
02/03/2022
Data de registro
17/10/2023
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/10/2023
Última transação
17/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
REID, MONICA R
Unidade examinadora
N80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Clinova Limited
Representantes
Joseph V. Myers III SEYFARTH SHAW LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Chemical test reagents for medical usereagents for use in viral antigen detectionantibody detection and Polymerase Chain Reaction; medical diagnostic test strips for salivamucusbloodurinenasal swabnasopharyngeal swab and oropharyngeal swab analysis; diagnostic testing materials for medical usemedical diagnostic test media in the form of strips for detecting and measuring viral antigens and antibodies; reagents for use in medical testing; chemical preparations for testing for medical purposescell lysis solutionsRNA extraction solutionsvirus inactivating solutions in the nature of detergent buffers; reagents for use in diagnostic testsdiagnostic reagents for medical use in particular PCR polymerasePCR primerslabelled nucleotides for PCR in addition to the aforementioned cell lysis solutionsRNA extraction solutionsvirus inactivating solutionslabelled antibodies; tests comprised of reagents for medical purposes; Testing kits comprised of medical diagnostic reagents and assays for testing the presence of antibodies and viruses; sanitizing preparations for household use; antimicrobial skin sanitizer gels; chemical preparations for sanitary use; disinfectants for sanitary use; sanitary preparations and articlessanitary preparations for medical use; hand-sanitizing preparations; disinfecting handwash; anti-microbial handwashes and hand lotions; pharmaceuticalsmedical and veterinary preparations for the treatment and prevention of airborne viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical and veterinary usefood for babies; dietary supplements for human beings and animals; medical plastersmaterials for dressings in the nature of gauze for dressings; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; testing kits for medical purposesdiagnostic test kits comprised of medical diagnostic reagents to diagnose influenza and respiratory infections
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/01/2024
FIMP
FINAL DISPOSITION PROCESSED
18/01/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
17/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/08/2023
PUBO
PUBLISHED FOR OPPOSITION
01/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/05/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
25/05/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
18/04/2023
GNFR
FINAL REFUSAL E-MAILED
18/04/2023
CNFR
FINAL REFUSAL WRITTEN
18/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2023
RFNT
REFUSAL PROCESSED BY IB
06/03/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/02/2023
RFRR
REFUSAL PROCESSED BY MPU
09/02/2023
ATRV
ATTORNEY REVIEW COMPLETED
10/01/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
09/01/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/12/2022
CNRT
NON-FINAL ACTION WRITTEN
14/12/2022
DOCK
ASSIGNED TO EXAMINER
14/12/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
06/11/2022
MAFR
APPLICATION FILING RECEIPT MAILED
30/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/08/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/08/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COVAFLU ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.